Monografie
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy
- Sprache
-
Englisch
- Identifier
-
1306179521
- Beteiligte Personen und Organisationen
-
Marone, Romina
Landmann, Emmanuelle
Devaux, Anna
Lepore, Rosalba
Rositzka, Julia
Rhiel, Manuel
Geoffroy, Andrieux
Cathomen, Anton
Cornu, Tatjana I.
Jeker, Lukas T.
- DOI
-
10.1084/jem.20231235
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
07.12.2023, 15:21 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Monografie
Beteiligte
- Marone, Romina
- Landmann, Emmanuelle
- Devaux, Anna
- Lepore, Rosalba
- Rositzka, Julia
- Rhiel, Manuel
- Geoffroy, Andrieux
- Cathomen, Anton
- Cornu, Tatjana I.
- Jeker, Lukas T.
Ähnliche Objekte (12)
Optimization of adoptive immunotherapy with genetically engineered T cells
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Engineered extracellular vesicles for immunotherapy of chronic lymphocytic leukemia (CLL)
Genetically engineered CD4+ T cells for immunotherapy of Hodgkin lymphoma
Genetically engineered antigen-specific treg cells in immunotherapy: opportunities and challenges
Optimization of engineered T cells for the use in melanoma immunotherapy
Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients
Targeted Fucosylation of Glycans with Engineered Bacterial Fucosyltransferase Variants
Targeted gene delievery to hematopoietic progenitor & specialized endothelial cells
Targeted gene transfer to enhance safety and efficacy of immunotherapy
"CAR-engineered lymphocytes for targeted therapy of leukemia and lymphoma"
Combinations of costimulatory antibody-ligand fusion proteins for targeted cancer immunotherapy
Optimization of adoptive immunotherapy with genetically engineered T cells
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Engineered extracellular vesicles for immunotherapy of chronic lymphocytic leukemia (CLL)
Genetically engineered CD4+ T cells for immunotherapy of Hodgkin lymphoma
Genetically engineered antigen-specific treg cells in immunotherapy: opportunities and challenges
Optimization of engineered T cells for the use in melanoma immunotherapy
Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients
Targeted Fucosylation of Glycans with Engineered Bacterial Fucosyltransferase Variants
Targeted gene delievery to hematopoietic progenitor & specialized endothelial cells
Targeted gene transfer to enhance safety and efficacy of immunotherapy
"CAR-engineered lymphocytes for targeted therapy of leukemia and lymphoma"
Combinations of costimulatory antibody-ligand fusion proteins for targeted cancer immunotherapy
Optimization of adoptive immunotherapy with genetically engineered T cells
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Engineered extracellular vesicles for immunotherapy of chronic lymphocytic leukemia (CLL)
Genetically engineered CD4+ T cells for immunotherapy of Hodgkin lymphoma
Genetically engineered antigen-specific treg cells in immunotherapy: opportunities and challenges
Optimization of engineered T cells for the use in melanoma immunotherapy
Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients
Targeted Fucosylation of Glycans with Engineered Bacterial Fucosyltransferase Variants
Targeted gene delievery to hematopoietic progenitor & specialized endothelial cells
Targeted gene transfer to enhance safety and efficacy of immunotherapy
"CAR-engineered lymphocytes for targeted therapy of leukemia and lymphoma"